INFORECERCA: Butlletí Informatiu del Servei de Recerca de l'IMIM
Número: 881
29/11/2024
Comentaris i suggeriments
Banner-noves-convocatories-02
Cercador de convocatòries
Projectes
02/01/2025
FUNDACIÓN ASOCIACIÓN ESPAÑOLA DE COLOPROCTOLOGÍA
Aportar tot el suport possible a la recerca independent per part dels seus socis i el moment del seu desenvolupament per a la generació i difusió del coneixement científic en el camp de la Coloproctologia.
Es convoquen 6 beques de recerca per a la realització de treballs a Espanya.
 
27/01/2025
Sarcoma Foundation of America
One-year grants to support pre-clinical, translational, and clinical research on the etiology, molecular biology, pathogenesis, diagnosis, and treatment of human sarcomas.
 
06/01/2025
GRADUATE WOMEN IN SCIENCE
The GWIS National Fellowships Program offers $10,000 grants for projects conducted by women in STEM, Life Science, and related Social Science fields.
 
03/03/2025
GILEAD COLORADO - GILEAD SCIENCES INC
The program is designed to support pre-clinical and clinical research in the field of HIV investigations.
 
27/01/2025
ALZHEIMER'S DRUG DISCOVERY FOUNDATION
The ADDF provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer's and related dementias.
 
Borses de viatge
17/01/2025
European Society for Medical Oncology
Short-term fellowships that enable young oncologists to spend time at a leading cancer care centre in Europe
 
Premis
02/01/2025
FUNDACIÓN ASOCIACIÓN ESPAÑOLA DE COLOPROCTOLOGÍA
Es convoquen els Premis Nacionals amb la denominació de “Premis Nacionals de la FAECP” Medtronic 2025 i es premiarà als millors treballs de Coloproctologia publicats per 1a vegada en qualsevol revista nacional o estrangera durant 2024.
 
Recursos Humans
07/02/2025
EMBO - THE EUROPEAN MOLECULAR BIOLOGY ORGANIZATION
The EMBO Postdoctoral Fellowships are awarded for a period of up to two years and support excellent postdoctoral researchers in laboratories throughout Europe and the world. International exchange is a key requirement.
 
10/02/2025
EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES (EFSD)
The objective of the EFSD/Lilly Young Investigator Research Awards is to encourage innovative research in the fields of diabetes and its complications, and to promote excellence in medical education. Applicants should have demonstrated their ability in the field of diabetes research.
 
 
 
Informació últil
 
 
 
Banner-convocatories-tancament-02
Projectes
13/12/2024
FUNDACIÓN LUCHA CONTRA LA CEGUERA (FUNDALUCE)
Per al finançament d'un projecte d'investigació sobre possibles estratègies terapèutiques concretes en el camp de les Distròfies Hereditàries de Retina (DHR)
 
20/12/2024
ALZHEIMER'S DRUG DISCOVERY FOUNDATION
Funding for projects to develop digital biomarkers for Alzheimer's disease and related dementias.
 
20/12/2024
ALZHEIMER'S DRUG DISCOVERY FOUNDATION
Funding for projects to develop biomarkers for Alzheimer's disease and related dementias accessible from the periphery.
 
Borses de viatge
24/12/2024
DAAD - DEUTSCHER AKADEMISCHER AUSTAUSCH DIENST
This programme offers you the opportunity to network amongst colleagues and exchange experience in the framework of short-term research stays in Germany.
 
25/12/2024
EUROPEAN RESPIRATORY SOCIETY
1-3 months fellowships for scientists, physicians or qualified allied health professionals, in the early stage of their career, going to another European or overseas country.
 
24/12/2024
SEIMC - SOCIEDAD ESPAÑOLA DE ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLÍNICA
Finançar estades curtes dels seus membres per a intercanvi de coneixements i experiències entre grups de treball dins del país o a l'estranger a l'àmbit de la Microbiologia Clínica i de les Malalties Infeccioses.
 
Premis
24/12/2024
CHAMPALIMAUD FOUNDATION
The 2025 António Champalimaud Vision Award recognises groups that contributed to the fight against blindness and visual impairment, primarily in developing regions and/or have developed innovations or new technologies that impact on the quality of life of the blind and visually impaired.
 
24/12/2024
FUNDACIÓN GRÜNENTHAL
Premiar a treballs que versin sobre el dolor, tant en l'àmbit epidemiològic, com experimental, farmacològic o clínic.
 
24/12/2024
AEESME - ASOCIACIÓN ESPAÑOLA DE ENFERMERÍA DE SALUD MENTAL
Estudis relacionats amb la recerca en el camp de la Infermeria de Salut Mental.
 
24/12/2024
EFIS - EUROPEAN FEDERATION OF IMMUNOLOGICAL SOCIETIES
The ACTERIA Prizes are awarded to recognize and reward Europe's young scientists in the fields of immunology and allergology. The Prizes, two each in immunology and allergology, honor outstanding achievements in fundamental research performed in a European institute by researchers with up to 10 years postdoctoral research experience and doctoral theses defended in the last 3 years before the award. The ACTERIA Prizes include individual cash awards plus the potential funding of three-year research projects to be performed in European institutions.
 
08/12/2024
THE GRUBER FOUNDATION
The Genetics Prize awards individuals who have made original discoveries in the fields of genetic function, regulation, transmission, or variation or in genomic organization.
 
08/12/2024
THE GRUBER FOUNDATION
The Neuroscience Prize honors scientists for major discoveries that have advanced the understanding of the nervous system.
 
13/12/2024
FUNDACIÓ IMIM
Hospital del Mar Research Institute (HMRIB) grants specific aids for the completion of doctoral theses with European mention, aimed at the staff of the Parc de Salut Mar and la Fundació Institut Mar d’Investigacions Mèdiques (In the following, Foundation). The grants are intended for final reprography and binding expenses.
This year's call is aimed at the completion of doctoral theses with European mention that are submitted for their reading during the year 2024.
 
Recursos Humans
24/12/2024
DAAD - DEUTSCHER AKADEMISCHER AUSTAUSCH DIENST
The research grant offers the opportunity to realise a research project in Germany. The programme sup-ports research stays during a doctorate or in the early postdoc phase.
 
 
 
 
Articles
 
Parra-Navarro L*, March-Rodriguez A, Planella-Fontanillas N, Pujol RM. Infantile Hemangiomas of the Vulvar Region: A Therapeutic Challenge. Actas Dermosifiliograf 2024: (en Premsa).
 
Blanco G*, Morris E, Morris JL, Letson HL, Susheel S, Puiggros A, Espinet B, Chiorazzi N, Dobson GP. Spontaneous Regression Accompanied by Concomitant Immune Alterations in a Patient with Chronic Lymphocytic Leukemia. Ann Case Rep . 2024; 9(1): 1539.
 
Pena R*, Pascual M. Patient-Reported Outcome Measures (PROMs) in colorectal cancer surgery. Cir Espan 2024: (en Premsa).
 
Morales-Santos A*, Lojo-Lendoiro S, Rovira-Cañellas M, Valdés-Solís P. The legal regulation of artificial intelligence in the European Union: A practical guide for radiologists. Radiología 2024; 66(5): 431-446.
 
Pham U, Chundi A, Stepniewski T, Darbha S, Eiger DS, Gazula S, Gardner J, Hicks C, Selent J, Rajagopal S*. Location-biased β-arrestin conformations direct GPCR signaling. bioRxiv . 2024: .
 
Palomar-Cros A, Deprato A, Papantoniou K, Straif K, Lacy P, Maidstone R, Adan A, Haldar P, Moitra S, Navarro JF, Durrington H, Moitra S, Kogevinas M, Harding BN*. Indoor and outdoor artificial light-at-night (ALAN) and cancer risk: A systematic review and meta-analysis of multiple cancer sites and with a critical appraisal of exposure assessment. Sci Total Environ . 2024; 955: (en Premsa).
 
Lin TY, Motamedi S, Asseyer S, Chien C, Saidha S, Calabresi PA, Fitzgerald KA, Samadzadeh S, Villoslada P, Llufriu S, Green AJ, Preiningerova JL, Petzold A, Leocani L, Garcia-Martin E, Oreja-Guevara C, Outteryck O, Vermersch P, Balcer LJ, Kenney R, Albrecht P, Aktas O, Costello F, Frederiksen J, Uccelli A, Cellerino M, Frohman EM, Frohman TC, Bellmann-Strobl J, Schmitz-Hübsch T, Ruprecht K, Brandt AU, Zimmermann HG*, Paul F. Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness z Scores. Neurol Neuroimmunol Neuroinflamm 2024; 11(5): e200269.
 
López-Campos JL*, Manresa-Presas F, Ruiz-Manzano J, Perpiñá M, Casán P, García-Río F, Barreiro E, Martinez García M.A. Archivos de Bronconeumología: 60 Years and Going on. Arch Bronconeumol 2024: (en Premsa).
 
Sendra E, Fernandez-Muñoz A, Zamorano L, Oliver A, Horcajada JP*, Juan C, Gómez-Zorrilla S*. Impact of multidrug resistance on the virulence and fitness of Pseudomonas aeruginosa: a microbiological and clinical perspective. Infection 2024; 52: 1235-1268.
 
Gasbjerg LS, Rasmussen RS, Dragan A, Lindquist P, Melchiorsen JU, Stepniewski T, Schiellerup S, Tordrup EK, Gadgaard S, Kizilkaya HS, Willems S, Zhong Y, Wang Y, Wright SC, Lauschke VM, Hartmann B, Holst JJ, Selent J, Rosenkilde MM*. Altered desensitization and internalization patterns of rodent versus human glucose-dependent insulinotropic polypeptide (GIP) receptors. An important drug discovery challenge. Br J Pharmacol 2024: (en Premsa).
 
Gómez-Zorrilla S*, Becerra F, Sendra E, Zamorano L, Grau I, Pintado V, Padilla B, Benito N, Boix L, Fariñas MDC, Penaranda M, Gamallo MR, Martinez JA, Morte-Romea E, Del Pozo JL, Lopez Montesinos I, Duran X, Ponz R, Cortarelo M, Cantón R, Oliver A, Ruiz-Garbajosa P, Horcajada JP*, ITUBRAS-2 Group. Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in Spain. J Hosp Infect 2024; 151: 173-185.
 
Cubelos-Fernández N, Dávila-Batista V*, Fernández-Villa T, Castaño Vinyals G, Pérez Gómez B, Amiano P, Ardanaz E, Delgado-Sillero I, Llorca J, Fernández Tardón G, Alguacil J, Vanaclocha M, Marcos-Gragera R, Moreno V, Aaragonés N, Dorronsoro A, Guevara M, Reguero S, Pollán M, Kogevinas M, Martín V. Burden of postmenopausal breast cancer attributable to excess body weight: comparative study of body mass index and CUN-BAE in MCC-Spain study. J Epidemiol Community Health 2024: (en Premsa).
 
Fa-Binefa M, Clará A, Lamas C, Elosua R*. Mediterranean Diet and Risk of Hip Fracture: A Systematic Review and Dose-Response Meta-Analysis. Nutr Rev 2024: (en Premsa).
 
García-Cosio MD*, Cruzado JM, Farrero M, Peiró MTB, Crespo M, Delgado-Jiménez JF, Diaz-Molina B, Fernandez-Rivera C, Bravo IPG, López-Jiménez V, Melilli E, Mirabet-Pérez S, Pérez-Tamajon ML, Sousa DR, Rodrigo-Calabia E, Hernández-Marrero D*. Management of heart disease in renal transplant recipients: a national Delphi survey-based SET/SEC/SEN consensus document. Rev Esp Cardiol 2024: (en Premsa).
 
Gonzáles JA, Barrera M, Kossatz de Mello E, Veza E, de la Torre R, Busquets A*, Robledo P*, Pizarro N*. Microbiota and social behavior alterations in a mouse model of down syndrome: Modulation by a synbiotic treatment. Prog Neuro-Psychopharmacol Biol Psychiatr 2024; 136: (en Premsa).
 
Ruiz-Limón P, Muralidharan J, Gómez-Pérez AM, Murri M, Vioque J, Corella D, Fitó Colomer M, Vidal Alaball J, Salas Salvadó J, Torres-Collado L, Coltell O, Atzeni A, Castañer O, Bulló M, Bernal-López MR, Moreno-Indias I*, Tinahones FJ. Physical activity shifts gut microbiota structure in aged subjects with overweight/obesity and metabolic syndrome. Biol Sport 2024; 41: 47-60.
 
Tur-Martínez J*, Rodríguez-Santiago J, Osorio-Aguilar J, Miró M, Yarnoz C, Jofra M, Ferret G, Salvador-Roses H, Fernández-Ananín S, Clavell A, Luna A, Aldeano A, Olona C, Hermoso J, Güell-Farré M, Dal Cero M, Gimeno M, Pallarès N, Pera M. Prognostic Relevance of Preoperative Immune, Inflammatory, and Nutritional Biomarkers in Patients Undergoing Gastrectomy for Resectable Gastric Adenocarcinoma: An Observational Multicentre Study. Cancers 2024; 16(12): 2188.
 
Sharma M*, Beaudart C, Clark P, Fujiwara S, Adachi JD, Papaioannou A, Messina OD, Morin SN, Kohlmeier L, Nogués X, Leckie C, Harvey NC, Kanis JA, Reginster JY, Hiligsmann M, Silverman SL. Clinical and demographic factors determining patient fracture risk decision point (FRDP): The improving risk communication in osteoporosis (RICO) project. Osteoporosis Int 2024: (en Premsa).
 
La Chica Lhöest M.T, Martinez A, Claudi L, Garcia E, Benitez Amaro A, Polishchuk A, Piñero J, Viladés-Medel D, Guerra JM, Sanz F, Rotllan N, Escolà-Gil JC, Llorente-cortés V*. Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis. Front Cardiovasc Med . 2024; 11: (Acceptat).
 
Mateu-Arrom L*, Giménez-Arnau AM, Expósito-Serrano V, Bonfill-Ortí M, Serra-Baldrich E, Yelamos O, Spertino J. Cyclosporine for the treatment of chronic spontaneous urticaria refractory to antihistamines and omalizumab: a case series. Int J Dermatol 2024: (en Premsa).
 
Lakhwani S*, Mateos MV, Martínez-López J, Paiva B, Rosiñol-Dachs L, Martínez R, Oriol A, Bargay J, González-Montes Y, Gironella M, Encinas C, Martín J, Jarque I, Granell M, Abella E, García-Mateo A, Hernández-Rivas JA, Ramila E, Krsnik I, Casado-Montero LF, de Arriba F, Palomera L, Sampol A, Moraleda JM, Casanova M, Delgado P, Lafuente A, Amutio E, López-Martínez A, Altés A, Ruíz MÁ, Alegre A, López-Anglada L, De La Cruz J, Alonso-Fernández R, Bladé-Creixenti J, Lahuerta JJ, San-Miguel J, Hernández MT. Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease. Ann Hematol 2024: (en Premsa).
 
Calpe-Damians N*, Wennberg-Capellades L, Ventura-Rosado A, Gonzalez-Engroba R, Enríquez-Pérez N, Vicario-Martos C, Roldos-Gales A, Guri T, Rafart-Aguado S, Ramírez-Ramon A, Llauradó-Serra M. Effectiveness and safety of a simple catheter securement device aimed at preventing catheter-associated urinary tract infection in intensive care unit patients: A randomized controlled trial. NURS CRIT CARE 2024; 29: 1788-1798.
 
Bootsma E*, Voorspoels W, Proost S, Jansen L, Mortier P, Van Den Houte K, Kessler RC, Kiekens G, Tack J, Alonso J, Bruffaerts R, Raes J, Falony G, Vieira-Silva S, Van Oudenhove L, Cuijpers P, Auerbach RP, Gut-Brain Interactions ? WHO ? World Mental Health International College Student Initiative Working Group. Beyond the Norm: Epidemiology of Irritable Bowel Syndrome and Mental Health Among Sexual and Gender-Diverse Young Adults in a Large Representative Cohort. Gastroenterology 2024; 167: 1213-1216.
 
Marcos-Delgado A*, Martín Sánchez V, Molina-Barceló A, Alonso-Molero J, Pérez Gómez B, Pollán M, Aaragonés N, Ederra-Sanza M, Fernández Tardón G, Binefa G, Moreno V, Barrios-Rodríguez R, Amiano P, Huerta JM, Teso EP, Alguacil J, Castaño Vinyals G, Kogevinas M, Molina de la Torre AJ. Health-Related Quality of Life in Long-Term Colorectal Cancer Survivors. Healthcare (Basel) . 2024; 12(19): 1917.
 
Márquez-Rodas I*, Alvárez A, Arance A, Valduvieco I, Berciano-Guerrero MA, Delgado R, Soria A, López-Campos F, Sánchez P, Romero JL, Martín-Liberal J, Lucas A, Diaz-Beveridge R, Conde-Moreno AJ, Álamo De La Gala MDC, García-Castaño A, Prada PJ, González-Cao M, Puertas E, Vidal J, Foro P, Aguado-De La Rosa C, Corona JA, Cerezuela-fuentes P, López P, Luna P, Aymar N, Puértolas T, Sanagustín P, Berrocal A. Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study). Neuro Oncol 2024; 26: 2074-2083.
 
Verlingue L, Italiano A, Prenen H, Guerra-Alia EM, Tosi D, Perets R, Lugowska I, Moiseyenko V, Gumus M, Arslan C, Lindsay CR, Deva S, Taus A, Oaknin A, Rottey S, Cicin I, Goksu SS, Smolin A, Roselló-Keränen S, Habigt C, Marbach D, Boetsch C, Dejardin D, Sleiman N, Evers S, Richard M, Ardeshir C, Charo J, Kraxner A, Teichgräber V, Keshelava N, Dziadziuszko R*. Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma. EBioMedicine 2024; 109: (en Premsa).
 
 
Institut Hospital del Mar d'Investigacions Mèdiques
Tel: 93 316 04 00
Doctor Aiguader, 88
08003 Barcelona
Seguiu-nos a:
Twitter
Youtube
En compliment de la Llei 34/2002, de Serveis de la Societat de la Informació i de Comerç Electrònic, aquest correu li hem enviat a partir de les dades de contacte que vostè ens ha facilitat. Si vostè no desitja rebre més comunicats, pot donar-se de baixa dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es) tot indicant la paraula “baixa base de dades” a l’assumpte.
Li recordem que podrà exercir els drets d’accés, rectificació, cancel·lació i oposició dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es).